Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Chimeric monoclonal antibody against claudin-18 splice variant 2

EU orphan designation number: EU/3/13/1177   
Active ingredient: Chimeric monoclonal antibody against claudin-18 splice variant 2
Indication: Treatment of pancreatic cancer
Sponsor: GE Healthcare AS
Nycoveien 1-2, P.O.Box 4220 Nydalen, 0401 OSLO, Norge

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Orphan designation EMA/OD/071/13 (2013)5276 of 05/08/2013
24/10/2014 Change of name and/or address of sponsor
22/05/2017 Change of name and/or address of sponsor